New paradigms in drug R&D: A personal perspective
The Author discusses the recent productivity problems in the pharmaceutical industry, in the context of his 30 year career, and the current responses of the industry driven strongly by disaggregation of the historic R&D model, new fluidites of capi…
New paradigms in drug R&D: A personal perspective Read Post »